Close
Digital Health & Ai Innovation summit 2026
APE 2026

News

New self-regulating nanoparticles could treat cancer

Scientists from the University of Surrey have developed ‘intelligent’ nanoparticles which heat up to a temperature high enough to kill cancerous cells – but which...

High Sample Throughput and Research Grade Results Delivered By New Multi-Technique Surface Analysis System

Materials researchers, product developers and failure analysis scientists seeking to conduct cost-effective, research-level x-ray photoelectron spectroscopy (XPS) studies in academic and corporate laboratories can now...

Ascom wins another long term critical communication service contract with leading Amsterdam academic hospital

Ascom succeeds to extend its partnership with the academic hospital Academisch Medisch Centrum (AMC) by five years. The service contract underlines AMC's trust in the...

UK’s First Varian Halcyon Cancer Treatment Systems Scheduled for Queen’s Hospital

Cancer patients in the U.K. will gain access to the country’s first Varian Halcyon™ radiotherapy treatment devices when the first of two systems are delivered...

Bulovka Hospital first in Czech Republic to offer advanced cancer treatment using Elekta Versa HD

Elekta announced that Bulovka Hospital in Prague will modernize its radiation therapy products and services with Elekta solutions. The cutting-edge technology includes two Versa HD™...

MagVenture Ltd: New UK subsidiary offers non-pharmaceutical depression treatment and high-end solutions for brain research

MagVenture A/S, a global medical device company, has established a subsidiary in the UK. MagVenture specializes in magnetic stimulation, a technology used within the fields of...

National Cancer Institute designates UCLA brain cancer program a site of research excellence

The brain cancer program at UCLA’s Jonsson Comprehensive Cancer Center and the UCLA Brain Tumor Center has been designated a Specialized Program of Research Excellence,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »